Pharmgate concludes merger with ProtaTek International, Inc.

Wilmington NC. October 12, 2016 – Pharmgate LLC announced today that it has successfully concluded its merger with ProtaTek International, Inc., which will continue to operate as a wholly owned subsidiary. Former ProtaTek board members, Roger Headrick and Dr. Shi-Jun Ma, will be retained on the board of the company.

Pharmgate announces agreement to acquire ProtaTek International, Inc.

Wilmington NC. September 15, 2016 – Pharmgate LLC is pleased to announce an agreement to merge with ProtaTek International, Inc., a developer and manufacturer of vaccines for swine, whereby ProtaTek International Inc. will become a wholly owned subsidiary.

Pharmgate announces new appointments.

August 1, 2016 – Pharmgate is pleased to announce the appointment of three animal health professionals.

Dr. James Skinner is appointed as Director of Clinical Development. James holds MS and PhD degrees in Poultry Science and Poultry Nutrition from Louisiana State and the University of Arkansas and is well acquainted with the industry through his previous career in technical service, clinical research and product development positions with Alpharma and Huvepharma.

Pharmgate Joins GVL® FeedLINK® Electronic VFD System

January 6, 2016 – GVL® announced a partnership with Pharmgate Animal Health. This new relationship will assure Pharmgate Animal Health’s antibiotics are a part of FeedLINK® electronic Veterinary Feed Directive (eVFD) system.

Starting December 2016, additional drugs will need a VFD from a veterinarian and FeedLINK will incorporate these into the system for fast fulfillment. The FeedLINK system’s complete drug database is due to collaboration from animal health companies Elanco, Huvepharma, and now Pharmgate.

Pharmgate Animal Health relocates headquarters and expands field team.

August 13, 2015 – Pharmgate is pleased to announce the relocation of its headquarters from Ramsey, New Jersey to Wilmington, North Carolina. The new office will house approximately 10 employees involved with corporate functions and customer service for Canada and Latin America. The Omaha, Nebraska manufacturing plant and office will continue to house supply chain, customer service and accounting functions for the domestic US business.

Pharmgate announces agreement to acquire the assets of Pennfield Animal Health.

October 16, 2014 - harmgate LLC is pleased to announce an agreement to acquire Pennfield Animal Health. This acquisition will establish Pharmgate as a key supplier of finished medicated feed additive and water soluble products to the United States, Canadian, Mexican and Latin American livestock and poultry markets..

ECO Animal Health and its North American marketing joint venture, Pharmgate Animal Health, announce the sponsorship of a Research Fellowship in Applied Pharmacology at the Swine Medicine Education Center of Iowa State University.

August 1, 2014 - ECO Animal Health together with Pharmgate Animal Health are delighted to announce the launch of the ECO/Pharmgate Animal Health Research Fellowship in Applied Pharmacology at the Swine Medicine Education Center of Iowa State University. This fellowship provides resources to graduate students to enable them to obtain a world-class education at Iowa State University's College of Veterinary Medicine.

Pharmgate Animal Health announces two Sales and Marketing appointments.

August 1, 2014 – As Pharmgate Animal Health enters its next growth phase, it is pleased to announce the appointment of two animal health sales and marketing professionals.

Russ Siakel joined the company as Marketing Manager for the USA and Canada. He will also service certain southern Minnesota and northern Iowa accounts. Russ studied Biology at George Williams College and has an MBA from Indiana Wesleyan University. He has had a career in sales and product management with Pfizer, Boehringer-Ingelheim and Norbrook.

Pharmgate Animal Health announces the Canadian launch of Aivlosin® 17% Tylvalosin Medicated Premix for the treatment of porcine proliferative enteritis (PPE) associated with Lawsonia intracellularis infection in swine

March 17, 2014 - Ileitis can have a serious impact on swine producers’ profitability

  • ileitis, particularly the chronic form, remains widespread on many swine operations, resulting in poor feed conversion rates and weight gains
  • clinical signs may be subtle or absent; diagnosis by serology or PCR will confirm the presence of the disease
  • vets and producers can improve production performance through pig flow management and targeted treatment to reduce this form of the disease, a costly threat.

Pharmgate receives regulatory approval for its chlortetracycline product, Deracin® 22% Granular, in Canada.

November 25, 2013 - Pharmgate LLC of Ramsey, New Jersey proudly announces the approval of its flagship product, Deracin® 22% Granular Premix containing 22% chlortetracycline, by the Veterinary Drugs Directorate of Health Canada. As the majority owned US subsidiary of Jinhe Biotechnology, the largest manufacturer of chlortetracycline in the world, Pharmgate will become a significant supplier of branded chlortetracycline products in Canada.

Pharmgate acquires chlortetracycline product licenses in Latin America.

August 08, 2013 - Pharmgate LLC of Ramsey, New Jersey is pleased to announce the acquisition of a number of chlortetracycline product registrations in Latin America. As the majority owned US subsidiary of Jinhe Biotechnology, the largest manufacturer of chlortetracycline in the world, Pharmgate will become a significant supplier of its branded chlortetracycline products in the Latin American market.

Pharmgate holds first Advisory Board meeting at World Pork Expo.

June 13, 2013 - Pharmgate Animal Health, having launched its new macrolide antibiotic, Aivlosin Water Soluble Granules, in the US and Canada in 2012, held its first advisory board meeting at the World Pork Expo. Invited veterinarians representing...

Pharmgate Animal Health expands team.

February 4, 2013 - Dr. Ronald Kaptur is appointed as Technical Services Veterinarian based in Ames, Iowa. Dr. Kaptur began his career in clinical development where he monitored both clinical and field trials in swine...

Pharmgate Animal Health announces two key sales appointments.

November 19, 2012 – Pharmgate Animal Health is pleased to announce the appointment of two senior animal health sales professionals. Gene Spellman is appointed as National Account Manager covering the central Midwest and eastern States. Gene spent most of his career with Pfizer Animal Health in sales and strategic account management positions.

Aivlosin® Water Soluble Granules containing the novel macrolide antibiotic, tylvalosin, now authorized for use in swine in the USA.

September 1, 2012 -- ECO Animal Health Ltd of London, UK and its North American distribution joint venture, Pharmgate Animal Health are pleased to announce the US approval of ECO’s new macrolide antibiotic, Aivlosin® Water Soluble Granules, containing tylvalosin. Aivlosin is the only water medication approved for the control of porcine proliferative enteritis (PPE) associated with Lawsonia intracellularis infection in swine that does not require complementary treatment in the feed.

Pharmgate's parent company launches successful IPO in China

August 10, 2012 – Jinhe Biotechnology, parent of Pharmgate LLC, successfully completed an initial public offering of 27.23 million A shares of common stock at a price of 18 yuan ($2.82) per share, according to filings. The company raised 490.14 million yuan ($76.79 million) through the issuance. The shares are traded on the SME Board of the Shenzhen Stock Exchange. China Galaxy Securities served as the lead underwriter and Crowe Horwath China Certified Public Accountants LLP is the auditor.

Pharmgate announces new appointments.

August 10, 2012 – Pharmgate Animal Health is pleased to announce the appointment of Edward Seed as General Manager. Having started his career in South Africa with Elanco in product development and technical support, Ed moved on to serve in regional leadership roles in Roche's Animal Health business in Europe and North America, as well as Alpharma's International Sales and Swine Business Unit. He has spent the past 2½ years assisting in the startup of Pharmgate LLC and its marketing joint venture, Pharmgate Animal Health.

Pharmgate Animal Health establishes a presence in Canada and announces the first North American approval for Aivlosin®.

December 15, 2011 - Pharmgate Animal Health, the joint venture between ECO Animal Health Ltd of London, England and Pharmgate LLC of Ramsey, New Jersey is pleased to announce the formation of Pharmgate Animal Health Canada Inc. to distribute its parents’ veterinary products in the Canadian livestock and poultry markets. The new company has named Marc Loomes, Colin Gray and Bill Maxwell as Directors.

Pharmgate Animal Health appoints key management team.

May 5, 2010 - Pharmgate Animal Health is pleased to announce the appointments of Peter Criddle as Vice President of Finance & Operations (and interim General Manager) and Edward Seed as Vice President of Sales & Marketing. Together, Peter and Ed bring in excess of 40 years experience and a history of successful innovation and operations in the animal health industry. This experience, together with our value proposition which combines innovative therapeutic options with an optimized supply chain, will establish Pharmgate Animal Health as the dynamic new player in the animal health marketplace.

Pharmgate and ECO Animal Health establish a joint venture for the distribution of animal health products in North America.

March 17, 2010 - Pharmgate LLC of Ramsey, New Jersey and ECO Animal Health Ltd of London, England are pleased to announce the formation of Pharmgate Animal Health LLC. This jointly-owned company will distribute its owner’s veterinary products in the North American livestock and poultry markets.

BLUE BIRD LABELS

View Labels »

GLOBAL VET LINK

Visit Website »

NEWS

  • October 12, 2016 Pharmgate concludes merger with ProtaTek International, Inc.

    September 15, 2016 Pharmgate announces agreement to acquire ProtaTek International, Inc.

    January 6, 2016 - Pharmgate Joins GVL® FeedLINK® Electronic VFD System

    August 1, 2016 - Pharmgate announces new appointments.

    January 6, 2016 - Pharmgate Joins GVL® FeedLINK® Electronic VFD System

  • November 25, 2013 - Pharmgate receives regulatory approval for its chlortetracycline product, Deracin® 22% Granular, in Canada.

    August 13, 2015 - Pharmgate is pleased to announce the relocation of its headquarters from Ramsey, New Jersey to Wilmington, North Carolina.

  • March 17, 2014 - Pharmgate Animal Health announces the Canadian launch of Aivlosin® 17% Tylvalosin Medicated Premix for the treatment of porcine proliferative enteritis (PPE) associated with Lawsonia intracellularis infection in swine

    August 8, 2013 - Pharmgate acquires chlortetracycline product licenses in Latin America.

  • August 1, 2014 - ECO Animal Health and its North American marketing joint venture, Pharmgate Animal Health, announce...

    August 1, 2014 - Pharmgate Animal Health announces two Sales and Marketing appointments.

  • November 3, 2014 - Pharmgate concludes acquisition of Pennfield Animal Health

    October 16, 2014 - Pharmgate announces agreement to acquire the assets of Pennfield Animal Health.

CONTACT US

Pharmgate Animal Health LLC
1015 Ashes Drive, Suite 102
Wilmington, NC 28405
Tel: 1-800-380-6099
Fax: 910-679-8368

Pharmgate Animal Health Canada, Inc.
5204 Tenth Line, R.R. #2
Erin, Ontario N0B 1T0
Tel: 1-800-465-2450
Fax: 910-679-8368